BioStem Technologies, Inc. (BSEM) Tops Q3 EPS by 6c

BioStem Technologies, Inc. (OTC: BSEM) reported Q3 EPS of $0.42, $0.06 better than the analyst estimate of $0.36. Revenue for the quarter came in at $82.56 million versus the consensus estimate of $78.22 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.

You May Also Be Interested In

• Apple suing OpenAI over alleged misappropriation of trade secrets
• CORVEX (MOVE) files for 53.39M share offering by selling stockholders
• L&T Financial Holdings (LTFH:IN) PT Raised to INR380 at Axis Capital Limited